- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT04028011
Klinische Bewertung einer tragbaren Technologie zur Diagnose von Schlafapnoe
Evaluación clínica de Una tecnología Ambulatoria Para diagnóstico Del sueño
This trial will aim to test a new wearable device for the diagnosis of Sleep Apnoea.
Studienübersicht
Status
Intervention / Behandlung
Detaillierte Beschreibung
This clinical trial will test a new wearable device for the diagnosis of Sleep Apnoea against Multi-channel polygraphy and Polysomnography.
For Group 1 and Group 2, the patients who have been referred for a sleep apnoea diagnosis will undergo in-hospital overnight polysomnography while wearing the new wearable device. Performance (i.e. sensitivity and specificity) of the new device will be assessed against the gold standard system.
For Group 3 and 4, the patients who have been referred for a sleep apnoea diagnosis will undergo in-hospital overnight polysomnography while wearing the new wearable device and a CE-marked oximeter.
For Group 5, patients presenting clinical criteria of Restless Legs Syndrome who are being evaluated via sleep studies as part of a routine clinical care will undergo an overnight polysomnography while wearing the new wearable device system.
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Renard Pramono, PhD
- Telefonnummer: +447721 877020
- E-Mail: renard@acurable.com
Studienorte
-
-
-
Seville, Spanien
- Rekrutierung
- Hospital Virgen Macarena Sevilla
-
Kontakt:
- Jesus Gomez Sanchez, Dr
- E-Mail: orsina@acurable.com
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Probenahmeverfahren
Studienpopulation
Patients who have been referred for suspicion of sleep apnoea
Beschreibung
Inclusion Criteria:
- Patients who have been referred to a sleep clinic due to suspicion of sleep apnoea.
- patients between the age of 18 yo and 80 yo
Exclusion Criteria:
- who are not fluent in Spanish, or who have special communication needs.
- Known allergy to the adhesive dressing.
- patients with physical or mental impairments who would not be able to use the new technology on their own.
- patients with very loose/saggy skin in the neck area which would unavoidably result on AcuPebble swinging if moving the neck.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Beobachtungsmodelle: COHORT
- Zeitperspektiven: PROSPECTIVE
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Group 2: PSG and novel wearable device
75 patients will wear polysomnography at the same time as the Novel wearable device |
patient will wear novel wearable device overnight along with normal standard of care |
|
Group 3: PSG and novel wearable device (+ CE-marked pulse oximeter)
51 patients (plus up to 20% to account for possible dropouts) will wear polysomnography at the same time as the novel wearable device and a CE-marked pulse-oximeter. |
patient will wear novel wearable device overnight along with normal standard of care |
|
Group 4: Additional PSG and novel wearable device (+ CE-marked pulse oximeter)
Additional 75 consecutive patients will wear polysomnography at the same time as the novel wearable device and a CE-marked pulse-oximeter. |
|
|
Group 1: Test Group
A first group of ~10-15 patients will be recruited, chosen from those who have been referred for a sleep apnea diagnosis. This group will not be used for performance validation, but rather to train all relevant staff on the different steps of the protocol and for the initial investigation of some of the secondary objectives related to usability. |
|
|
Group 5: RLS
70 patients presenting clinical criteria compatible with Restless legs Syndrome and who are being evaluated for a sleep study as part of their routine clinical care will be included. The patients will wear standard polysomnography while simultaneously wearing the new wearable system (a total of 4 sensors: 1 sensor on the neck, 1 pulse oximeter on finger, and 1-2 sensors on the legs). |
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Sensitivities and Specificity for diagnosis of sleep apnoea studies with novel wearable device
Zeitfenster: 6 months
|
The study aims to compare the diagnosis result of the novel wearable device against standard of care |
6 months
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Jesus Fernando Sanchez Gomez, MD, Hospital Universitario Virgen Macarena
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 720/19/EC
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .